Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tylenol most recommended analgesic for people on "certain prescriptions," ad claims.

This article was originally published in The Tan Sheet

Executive Summary

TYLENOL MOST RECOMMENDED "FOR PEOPLE ON CERTAIN PRESCRIPTIONS," a new ad for McNeil Consumer Products' OTC acetaminophen analgesic says. The commercial, entitled "The Lake," shows an older woman preparing for a swim. "My doctor says I'm healthier than he is. I swim every day. And I take my blood pressure medicine regularly," she states. A voice-over says "If you're taking a prescription, speak to your doctor about the pain reliever you choose"; a super notes this "includes patients taking diuretics, calcium channel blockers and ACE inhibitors." For "people on certain prescriptions, Tylenol is the brand of pain reliever doctors recommend most. And Tylenol won't irritate your stomach," the ad says.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel